Skip to main content
Bora logo

Bora — Investor Relations & Filings

Ticker · 6472 ISIN · TW0006472004 LEI · 254900MK7O5C2UX1SY03 TW Manufacturing
Open in API
Filings indexed 63 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 6472

About Bora

https://bora-corp.com/

Bora Pharmaceuticals Co., Ltd. is a global pharmaceutical service provider that operates through a "dual-engine" business model, integrating comprehensive Contract Development and Manufacturing Organization (CDMO) services with the development and commercialization of specialty pharmaceuticals. The company provides end-to-end solutions ranging from formulation development and clinical trial materials to large-scale commercial manufacturing. Its technical capabilities encompass a diverse array of dosage forms, including oral solids, liquids, and semi-solids. With a manufacturing footprint spanning multiple continents, the company serves global markets by leveraging advanced production technologies and rigorous quality management systems. Bora Pharmaceuticals focuses on strategic growth through acquisitions and partnerships, aiming to enhance manufacturing efficiency and accelerate the delivery of complex therapeutic treatments to patients worldwide.

Recent filings

Filing Released Lang Actions
115年第1季權益變動表
Interim / Quarterly Report Classification · 92% confidence The document is the Consolidated Statement of Changes in Equity (“合併權益變動表”) for the first quarter (“第1季”) with detailed financial line items and opening/closing balances. It is part of a quarterly financial filing containing actual financial statements for a period shorter than a fiscal year. Therefore, it should be classified as an Interim / Quarterly Report. Q1 2026
2026-05-13 Chinese
115年第1季現金流量表
Regulatory Filings Classification · 10% confidence The text is a generic web page access error message in Chinese and English, with no substantive financial or corporate content. It does not match any specific filing category. As a fallback for miscellaneous or non-applicable filings, it is classified as a Regulatory Filing (RNS).
2026-05-13 Chinese
115年第1季綜合損益表
Regulatory Filings Classification · 10% confidence The provided text is an error message indicating a page access issue with no substantive financial, corporate, or regulatory content. It does not match any specific filing category and serves as a fallback scenario.
2026-05-13 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 98% confidence The document is a standalone set of detailed consolidated financial statements (balance sheet) for the first quarter of the fiscal year (民國115年第1季), including actual line-by-line financial data. It is not merely an announcement or link to a report but contains substantive interim financial statements for a period shorter than a full fiscal year. Therefore, it qualifies as an Interim/Quarterly Report. Q1 2026
2026-05-13 Chinese
公告本公司董事會通過115年第一季合併財務報告
Interim / Quarterly Report Classification · 90% confidence The document is a disclosure from the company to the public information observatory announcing that its board approved the consolidated financial report for the first quarter (January 1 to March 31). It includes substantive financial data—revenues, gross profit, operating income, net income, EPS, total assets, liabilities, and equity—covering a period shorter than a full fiscal year. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-13 Chinese
115年5月12日內部人設質解質
Director's Dealing Classification · 90% confidence The document is a disclosure table of share pledge transactions by an insider (董事法人代表人) listing pledged and released shares, pledgee, and dates. This constitutes an insider transaction report (Director’s Dealing), not a company buyback or capital change. Thus it matches Code DIRS (Director’s Dealing).
2026-05-13 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.